PHARMOS CORP Retained Earnings
PHARMOS CORP had Retained Earnings of -$214.62 million as of 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-11-19
- 2012-09-30: Retained Earnings (Accumulated Deficit) -$214.62M.
- 2012-06-30: Retained Earnings (Accumulated Deficit) -$214.29M.
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$213.91M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$213.33M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-09-30 | -$214.62M 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$214.29M 10-Q · filed 2012-07-30 |
| 2012-03-31 | -$213.91M 10-Q · filed 2012-04-16 |
| 2011-12-31 | -$213.33M 10-Q · filed 2012-11-19 |
| 2011-09-30 | -$212.90M 10-Q · filed 2011-10-31 |
| 2011-06-30 | -$212.46M 10-Q · filed 2011-08-08 |
| 2010-12-31 | -$211.35M 10-K/A · filed 2012-02-21 |